2-203252041-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_177538.3(CYP20A1):c.364A>G(p.Met122Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000256 in 1,611,768 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_177538.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000409 AC: 62AN: 151506Hom.: 0 Cov.: 27
GnomAD3 exomes AF: 0.000447 AC: 112AN: 250352Hom.: 0 AF XY: 0.000443 AC XY: 60AN XY: 135370
GnomAD4 exome AF: 0.000240 AC: 351AN: 1460144Hom.: 2 Cov.: 32 AF XY: 0.000264 AC XY: 192AN XY: 726430
GnomAD4 genome AF: 0.000409 AC: 62AN: 151624Hom.: 0 Cov.: 27 AF XY: 0.000419 AC XY: 31AN XY: 74064
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.364A>G (p.M122V) alteration is located in exon 4 (coding exon 4) of the CYP20A1 gene. This alteration results from a A to G substitution at nucleotide position 364, causing the methionine (M) at amino acid position 122 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at